Yersinia pestis caf1 variants and the limits of plague vaccine protection.
about
Characterization of systemic and pneumonic murine models of plague infection using a conditionally virulent strain.Synthetic {beta}-(1->6)-linked N-acetylated and nonacetylated oligoglucosamines used to produce conjugate vaccines for bacterial pathogensEfficacy and safety of a modified vaccinia Ankara (MVA) vectored plague vaccine in mice.Evaluation of YadC protein delivered by live attenuated Salmonella as a vaccine against plagueAmino acid residues 196-225 of LcrV represent a plague protective epitopeThe smpB-ssrA mutant of Yersinia pestis functions as a live attenuated vaccine to protect mice against pulmonary plague infectionGlutathionylation of Yersinia pestis LcrV and Its Effects on Plague PathogenesisYopJ-promoted cytotoxicity and systemic colonization are associated with high levels of murine interleukin-18, gamma interferon, and neutrophils in a live vaccine model of Yersinia pseudotuberculosis infectionMultiple antigens of Yersinia pestis delivered by live recombinant attenuated Salmonella vaccine strains elicit protective immunity against plagueA Yersinia pestis tat mutant is attenuated in bubonic and small-aerosol pneumonic challenge models of infection but not as attenuated by intranasal challengeAn encapsulated Yersinia pseudotuberculosis is a highly efficient vaccine against pneumonic plagueVulnerabilities in Yersinia pestis caf operon are unveiled by a Salmonella vectorLcrV delivered via type III secretion system of live attenuated Yersinia pseudotuberculosis enhances immunogenicity against pneumonic plague.Immune responses to plague infection in wild Rattus rattus, in Madagascar: a role in foci persistence?The dependence of the Yersinia pestis capsule on pathogenesis is influenced by the mouse background.Plague in Guinea pigs and its prevention by subunit vaccinesContributions of chaperone/usher systems to cell binding, biofilm formation and Yersinia pestis virulence.A naturally derived outer-membrane vesicle vaccine protects against lethal pulmonary Burkholderia pseudomallei infection.Humoral and cellular immune responses to Yersinia pestis infection in long-term recovered plague patients.Complete Protection against Pneumonic and Bubonic Plague after a Single Oral Vaccination.Polymorphisms in the lcrV gene of Yersinia enterocolitica and their effect on plague protective immunity.Yersinia pestis Caf1 Protein: Effect of Sequence Polymorphism on Intrinsic Disorder Propensity, Serological Cross-Reactivity and Cross-Protectivity of IsoformsIntramuscular Immunization of Mice with a Live-Attenuated Triple Mutant of Yersinia pestis CO92 Induces Robust Humoral and Cell-Mediated Immunity To Completely Protect Animals against Pneumonic Plague.Oral administration of a recombinant attenuated Yersinia pseudotuberculosis strain elicits protective immunity against plagueHereditary hemochromatosis restores the virulence of plague vaccine strains.Prevention of pneumonic plague in mice, rats, guinea pigs and non-human primates with clinical grade rV10, rV10-2 or F1-V vaccines.Immunization with recombinant V10 protects cynomolgus macaques from lethal pneumonic plagueA Replication-Defective Human Type 5 Adenovirus-Based Trivalent Vaccine Confers Complete Protection against Plague in Mice and Nonhuman Primates.Pneumonic plague pathogenesis and immunity in Brown Norway rats.Yersinia pestis IS1541 transposition provides for escape from plague immunity.Immunogenicity and safety of subunit plague vaccine: A randomized phase 2a clinical trial.High-throughput identification of new protective antigens from a Yersinia pestis live vaccine by enzyme-linked immunospot assay.Dual-function antibodies to Yersinia pestis LcrV required for pulmonary clearance of plagueRational considerations about development of live attenuated Yersinia pestis vaccinesProgress on plague vaccine development.Plague Vaccines: Status and Future.Intranasal delivery of a protein subunit vaccine using a Tobacco Mosaic Virus platform protects against pneumonic plague.Molecualr Cloning of the capsular antigen F1 of Yersinia pestis in pBAD/gIII plasmidToll-like receptor 6 drives differentiation of tolerogenic dendritic cells and contributes to LcrV-mediated plague pathogenesis.Immunisation of two rodent species with new live-attenuated mutants of Yersinia pestis CO92 induces protective long-term humoral- and cell-mediated immunity against pneumonic plague.
P2860
Q30414497-1F6AA3D5-F80A-45DC-BDE2-1C285427E978Q33613913-A2E96DD1-F050-4B62-9417-FF9E8D276CB8Q33635050-EEAEC3DE-7067-46CF-82E9-4BC7CDD1ED92Q33637474-B8D0391E-C2B3-4796-9533-C0EB761FC4DCQ33653622-CDA1CADB-AFF7-48EF-AA10-3746379F5EB5Q33675834-0AFD5A8D-A9DC-4567-BEDC-D5541F78D4F1Q33691879-26877366-A37E-4F08-ADD5-7544D2187FB0Q33826059-A5CEC7CD-2B0D-4B1A-8F1C-299DE90F015BQ33834427-DC0D433D-0E12-47BF-850E-93488A01F07BQ34016105-9D418892-45F4-41C8-9278-E218BA0E3894Q34163944-02F05274-6C91-497C-B6EE-5A2FDBD3A048Q34257405-8856A358-0927-4483-8ED4-02091C1B9F97Q34298699-CAB1351E-7695-4860-8A23-8F2CB8686AA7Q34311954-F63E7D5C-AE67-437C-A6BC-D4F12AF624BAQ34529535-59F41F73-74B0-46ED-BA77-DCB67B4AA9E5Q34805666-23050AB9-CD8F-43FA-B73E-B0BEFADF4387Q34837374-E58E2C94-87C7-4089-B02F-530962C2782EQ35375333-6DAF1B20-79B7-4909-9ACA-F611A7849579Q35739128-B31A49C1-8CEA-4B34-881D-546DD67603F5Q35810279-B0E067BC-E029-452F-8E2F-CFDCCDB12761Q35867550-75B283D7-D180-496C-836C-A46A168AFC75Q36126137-AD13F14E-1D7D-4107-A0E0-317D26E1B0ACQ36316792-AF939BDC-5492-45F9-BFCF-6CD66124C03EQ36372952-00431747-DC46-46C7-AE46-82C6A86E4FAAQ36410035-A3B82ABA-2C61-4410-94BF-2937490683B4Q36513899-7B4C2C4E-8458-4073-BD37-1895DEB3D7FDQ36974485-D4C5AB76-E03A-4798-9E0A-02AE7346A80BQ37067254-02491B87-1384-4C6A-9CC7-4FD2A42E12CCQ37150791-67F57AF6-64A0-4278-904E-A374BBAF7AD6Q37191268-9100C174-C780-43D7-B9EA-38E4E4338B85Q37264991-98B64DC3-9137-42D2-8BA9-9886C53DBCFEQ37355871-CC5068B2-7B80-4949-8B05-0487DC337DD5Q37450884-9955C310-77DF-47EB-9829-9AD0647AB7DEQ37688618-7C24CE18-7A26-434D-8C4E-B7C99F2DBE81Q37889155-B2ECF5D6-B323-49C7-8C07-6503D8DE26EAQ38813137-D1D954E4-2EA5-4C50-BF3B-6AEEBD8C40AEQ40485593-558AA35F-3968-406D-B69B-029CC49E6A7EQ40969023-6B2DF3EE-98CE-4D8F-B6C0-C64B0C33BD59Q41441657-6B718DEB-B6B0-4CA0-AD05-AE0A04C4BB6EQ47293934-DCAA5A79-6A7A-476C-8253-F68F5407C11D
P2860
Yersinia pestis caf1 variants and the limits of plague vaccine protection.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Yersinia pestis caf1 variants and the limits of plague vaccine protection.
@ast
Yersinia pestis caf1 variants and the limits of plague vaccine protection.
@en
type
label
Yersinia pestis caf1 variants and the limits of plague vaccine protection.
@ast
Yersinia pestis caf1 variants and the limits of plague vaccine protection.
@en
prefLabel
Yersinia pestis caf1 variants and the limits of plague vaccine protection.
@ast
Yersinia pestis caf1 variants and the limits of plague vaccine protection.
@en
P2093
P2860
P356
P1476
Yersinia pestis caf1 variants and the limits of plague vaccine protection.
@en
P2093
Claire A Cornelius
Derek Elli
Lauriane E Quenee
Nancy A Ciletti
P2860
P304
P356
10.1128/IAI.00105-08
P407
P577
2008-03-17T00:00:00Z